ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

NCI Predicts 42 Percent Increase In Number of Senior Survivors

October 28, 2011

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002